Nachrichten zur GETINGE AB B FR. SK-,50 Aktie

Global Hospital Acquired Infection Control Market Size To Worth USD 5.8 Billion by 2033 | CAGR of 3.53%

The Global Hospital Acquired Infection Control Market Size was Valued at USD 4.1 Billion in 2023 and the Worldwide Hospital…

Getinge makes a provision of MBRL 240 related to Brazilian investigation

Getinge makes a provision of MBRL 240, corresponding to approximately MSEK 480, related to the previously announced negotiations with the Brazilian…

Getinge to acquire Paragonix Technologies, a growth leader in the organ transplantation market

Today, Getinge announces an agreement to acquire 100% of Paragonix Technologies, Inc., a leading organ transport products and services company…

Getinge Enters Strategic Sales Partnership with SurgicalOne

Today, Getinge USA Sales, LLC and SurgicalOne, Inc. announced a new strategic distribution partnership in the promotion of autofluorescence and…

Getinge AB (GNGBF) Q2 2024 Earnings Call Transcript

…

Getinge AB (publ) reports Q2 results

…

Getinge Interim Report April-June 2024: Higher sales, stronger margins and product launches with significant added value for customers

“Net sales increased by 15.7% in the second quarter, of which the organic increase was 8.9%,” says Mattias Perjos, President…

Digitalization partnership streamlines sterile workflow in Japan

A renowned third-party sterilization service provider in Japan, medical bear, has forged a strategic partnership with Getinge in a transformation…

Should Weakness in Getinge AB (publ)s (STO:GETI B) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

With its stock down 10% over the past three months, it is easy to disregard Getinge (STO:GETI B). But if…

Getinge extends and elevates partnership with Universeum

Getinge announces the extension and elevation of its partnership with Universeum, Swedens national science center. This renewed commitment underscores Getinges…

Getinge launches Pulsiocare – the next generation in hemodynamic monitoring

Getinge announces the launch of Pulsiocare, an advanced hemodynamic monitoring platform that recently received its CE certificate. The state-of-the-art device…

Getinge invites fund managers, analysts, and media to Q2 Report 2024 conference call

Getinge will issue its Q2 Report 2024 on July 18, 2024, at 08:00 a.m. CEST, followed by a conference call…

Continuous ways to improve and innovate

Peta Ryan, Principal Analytical Development Chemist at Getinge, shares insights into her dynamic role at the Getinge’s Center for Excellence…

Father and son duo share a quarter-century journey at Getinge

In the heart of Getinge’s Merrimack production site in New Hampshire, a beautiful story unfolds where Jason and Frank Smith,…

Getinge receives U.S. FDA 510(k) clearance for Talis +ACG Clinical Decision Support software, pioneering quality of high-acuity care in US and EU

Getinge has been granted U.S. FDA 510(k) clearance for its innovative clinical decision support software Talis +ACG (Advanced Clinical Guidance),…

Getinge erhält 510(k)-Zulassung der FDA für die Talis +ACG-Software zur Unterstützung klinischer Entscheidungen

Getinge hat die 510(k)-Zulassung der amerikanischen Gesundheitsbehörde FDA für seine innovative klinische Entscheidungsunterstützungssoftware Talis +ACG (Advanced Clinical Guidance) erhalten, die…

Getinge Announces U.S. Launch of XEN Cleaning Chemistries to Enhance Safety and Efficiency in Sterile Processing Departments

Today Getinge announced the launch of XEN, a new and improved range of cleaning chemistries designed to optimize equipment performance,…

Getinge introduces Poladus 150 – the future of low-temperature sterilization

Today, Getinge unveils the Poladus 150, its latest innovation in low-temperature sterilization, designed for heat-sensitive surgical instruments. Equipped with advanced…

Getinge displays new life science solutions at ACHEMA 2024

At this year’s ACHEMA – the world’s leading forum for chemical engineering, process engineering and biotechnology – Getinge will demonstrate…

Getinge’s new lab sterilizer Lancer LSS offers unmatched efficiency and intuitive control

Today, Getinge introduces Lancer LSS, an innovative lab sterilizer where cutting-edge technology meets refined design. Its connectivity and control system…

Getinge and UpBeat Clean: Cleaning Up for a positive change in Derby

Were excited to announce a positive collaboration between Getinge and Upbeat Clean, a dynamic social enterprise in Derby. [image] As a global…

Getinge introduces DPTE-BetaBag® with material from renewable sources

Getinge demonstrates its commitment to sustainable innovations by launching a new version of the DPTE-BetaBag®, used in sterile transfer. A…

Getinges financial target 2024-2028: Adjusted EPS growth of above 12% on average

Getinge updates its financial target for adjusted EPS growth 2024-2028 to be above 12% on average. The target takes into…

Getinge invites fund managers, analysts and media to a Capital Market Update conference call

Getinge will host a Capital Market Update conference call on May 15, 2024, at 10:00-11:00 a.m. CEST (Swedish time) with…

Driven by curiosity and the ambition to build strong and diverse teams

Marcio Mazon draws on his curiosity and experience from a diverse background to leverage the opportunities and challenges in his…

Getinge’s cGMP washer redefines cleanroom efficiency with compact design and sustainable performance

Today, Getinge unveils the GEW 888 neo, a cGMP washer designed to develop cleanroom efficiency. Built to meet the strictest…

Getinge AB (GNGBF) Q1 2024 Earnings Call Transcript

…

Resolutions at Getinge’s Annual General Meeting 22 April 2024

Getinge AB (publ)’s Annual General Meeting (“AGM”) was held on 22 April 2024 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At…

Getinge Interim Report January-March 2024: Higher sales, strong cash flow and new products creating more customer value

“Net sales increased by 5.2% in the first quarter, of which organic net sales was unchanged despite challenging comparative figures,”…

Getinge receives EU MDR approval of Advanta V12 covered stent system with use for patients with renal artery stenosis and/or aortoiliac occlusive disease

Getinge announces the EU MDR certification of its Advanta V12 covered stent system, highlighting its use for patients with aortoiliac…

Getinge iCast covered stent system considered medically necessary for treatment of iliac arterial occlusive disease

Today, Getinge announced Aetna, a leading health insurance benefits company in the United States, issued a Clinical Policy Bulletin (CPB)…

Getinge invites fund managers, analysts, and media to Q1 Report 2024 conference call

Getinge will issue its Q1 Report 2024 on April 22, 2024, at 12:00 p.m. CEST, followed by a conference call…

Getinge South Asia Pacific launches three innovative OR solutions

Getinge South Asia Pacific has added three new products to its portfolio of operating room (OR) solutions. In addition to…

Getinge extends the bioreactor portfolio with larger single-use systems

Getinge is extending its bioreactor offering by introducing the Single-Use Production Reactor (SUPR) system, which initially is available in 50-liter…

Getinge donates life-saving medical equipment to Ukraine

In a time where medical assistance is critical, Getinge donates extensive medical equipment to Ukraine. The donation, made in collaboration…

Getinge publishes 2023 annual report

Today, Getinge publishes its 2023 annual report including a sustainability report, summarizing a year of huge contrasts. The global medtech…

Getinge enters into commercial distribution agreement with Cook Medical for iCast covered stent system in the United States

Today, Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered stent system, which has…

Getinge and CellRev launch platform with potential to transform allogeneic cell therapy manufacturing

Getinge has partnered with the bioprocessing company CellRev in the development of a continuous cell processing platform called Livit ACE…

A century and beyond with Getinge in medtech

Celebrating 120 years of pioneering healthcare, Getinge reflects on its journey in the industry. With a strong focus on continuous…

Medizintechnikunternehmen Getinge feiert 120-jähriges Bestehen

Getinge feiert 120 Jahre Pionierarbeit im Gesundheitswesen und blickt auf seine Reise in der Branche zurück. Mit einem starken Fokus auf…

The Global Operating Room Integration Systems Market: Emerging Trends and Regulatory Dynamics to 2033 Featuring Stryker, Steris, Olympus, Hill-Rom, and Getinge

Dublin, March 19, 2024 (GLOBE NEWSWIRE) -- The "Operating Room Integration Systems Market Size by Segments, Share, Regulatory,…

NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL)

The shareholders of Getinge AB (publ), corporate ID No. 556408-5032, (“Getinge”) are hereby invited to attend the Annual General Meeting…

Getinge takes a leap forward in cardiovascular surgery with the 510(k) clearance for Vasoview Hemopro 3

Today, Getinge announces the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of the Vasoview Hemopro 3, the latest addition…

Global Laboratory Glassware Washers Market Forecast Report 2023-2028, Featuring Profiles of Key Players ATS, Belimed, Getinge, LABINDIA, Smeg, Steelco and STERIS

Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Global Laboratory Glassware Washers Market - Outlook & Forecast 2023-2028"…

dpa-AFX ProFeed